Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies

Background Multiplex assays are increasingly applied to analyze multicomponent signatures of human immune responses, including the dynamics of cytokine and chemokine production, in observational as well as interventional studies following treatment or vaccination. However, relatively limited information is available on the performance of the different available multiplex kits, and comparative evaluations addressing this important issue are lacking. Study design To fill this knowledge gap we performed a technical comparison of multiplex bead assays from 4 manufacturers, each represented by 3 different lots, and with the assays performed by 3 different laboratories. To cross compare kits directly, spiked samples, biological samples and a newly made reference standard were included in all assays. Analyses were performed on 324 standard curves to allow for evaluation of the quality of the standard curves and the subsequent interpretation of biological specimens. Results Manufacturer was the factor which contributed most to the observed variation whereas variation in lots, laboratory or type of detection reagent contributed minimally. Inclusion of a common reference standard allowed us to overcome observed differences in cytokine and chemokine levels between manufacturers. Conclusions We strongly recommend using multiplex assays from the same manufacturer within a single study and across studies that are likely to compare results in a quantitative manner. Incorporation of common reference standards, and application of the same analysis method in assays can overcome many analytical biases and thus could bridge comparison of independent immune profiling (e.g. vaccine immunogenicity) studies. With these recommendations taken into account, the multiplex bead assays performed as described here are useful tools in capturing complex human immune-signatures in observational and interventional studies.

[1]  Caterina Guinovart,et al.  Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology , 2011, Malaria Journal.

[2]  M. Newport,et al.  BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and Malawi , 2011, The Journal of infectious diseases.

[3]  J. P. McCoy,et al.  Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers , 2004, Cytometry. Part B, Clinical cytometry.

[4]  H. Dockrell,et al.  Complex cytokine profiles induced by BCG vaccination in UK infants , 2010, Vaccine.

[5]  Gerhard Walzl,et al.  An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays , 2008, PloS one.

[6]  R. Sinden,et al.  Innate Immune Responses to Human Malaria: Heterogeneous Cytokine Responses to Blood-Stage Plasmodium falciparum Correlate with Parasitological and Clinical Outcomes1 , 2006, The Journal of Immunology.

[7]  P. Luciw,et al.  A comparison of multiplex suspension array large‐panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients , 2009, Cytometry. Part B, Clinical cytometry.

[8]  Y. Lévy,et al.  Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells , 2016, BMC Immunology.

[9]  Tatsuki Koyama,et al.  Accuracy and reproducibility of a multiplex immunoassay platform: a validation study. , 2011, Journal of immunological methods.

[10]  H. Dockrell,et al.  Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining , 2010, BMC Immunology.

[11]  J. Richens,et al.  Quantitative Validation and Comparison of Multiplex Cytokine Kits , 2010, Journal of biomolecular screening.

[12]  V. Seyfert-Margolis,et al.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.

[13]  J. Aponte,et al.  Performance of Multiplex Commercial Kits to Quantify Cytokine and Chemokine Responses in Culture Supernatants from Plasmodium falciparum Stimulations , 2013, PloS one.

[14]  Chahrazed Belabani,et al.  A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples. , 2013, Journal of immunological methods.

[15]  R. Kircheis,et al.  Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences , 2008, Biomarker insights.

[16]  N. Frahm,et al.  Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells. , 2012, Journal of immunological methods.

[17]  J. Margolick,et al.  Multisite Comparison of High-Sensitivity Multiplex Cytokine Assays , 2011, Clinical and Vaccine Immunology.

[18]  W. Kuis,et al.  Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells , 2003, Clinical Diagnostic Laboratory Immunology.